We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

274 hedge funds and large institutions have $4.55B invested in Intra-Cellular Therapies Inc. in 2023 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 110 increasing their positions, 86 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

277% more call options, than puts

Call options by funds: $54.4M | Put options by funds: $14.4M

33% more funds holding in top 10

Funds holding in top 10: 6 → 8 (+2)

28% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 86

4% more capital invested

Capital invested by funds: $4.38B → $4.55B (+$166M)

3% less funds holding

Funds holding: 283 → 274 (-9)

16% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 44

Holders
274
Holders Change
-9
Holders Change %
-3.18%
% of All Funds
4.37%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.13%
New
37
Increased
110
Reduced
86
Closed
44
Calls
$54.4M
Puts
$14.4M
Net Calls
+$40M
Net Calls Change
+$44.1M

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$82.2M
2
DM
Deerfield Management
New York
+$35.5M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$23.6M
4
ClearBridge Investments
ClearBridge Investments
New York
+$18.9M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$17.6M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$43.4M
2
Holocene Advisors
Holocene Advisors
New York
-$29.7M
3
APM
Avidity Partners Management
Texas
-$26.7M
4
NIP
Nicholas Investment Partners
California
-$21.9M
5
WP
Woodline Partners
California
-$20.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
QPW
151
Quantum Private Wealth
Florida
$807K -$37K -765 -5%
SG
152
Stonnington Group
California
$782K +$396K +8,200 +164%
FC
153
FORA Capital
Florida
$774K +$691K +14,292 New
FSA
154
Franklin Street Advisors
North Carolina
$750K -$7.25K -150 -1%
SEC
155
Seven Eight Capital
New York
$739K +$660K +13,655 New
Los Angeles Capital Management
156
Los Angeles Capital Management
California
$738K -$58.8K -1,217 -8%
AQR Capital Management
157
AQR Capital Management
Connecticut
$728K -$268K -5,542 -29%
HWAM
158
Hennion & Walsh Asset Management
New Jersey
$727K +$110K +2,280 +20%
AB
159
Amalgamated Bank
New York
$703K -$99K -2,048 -14%
ACM
160
Aquatic Capital Management
Illinois
$666K +$595K +12,300 New
Jennison Associates
161
Jennison Associates
New York
$666K -$182K -3,761 -23%
Handelsbanken Fonder
162
Handelsbanken Fonder
Sweden
$639K – – –
Citigroup
163
Citigroup
New York
$624K +$117K +2,416 +27%
PA
164
Profund Advisors
Maryland
$610K +$148K +3,065 +37%
QT
165
Quantbot Technologies
New York
$579K +$517K +10,694 New
Zurich Cantonal Bank
166
Zurich Cantonal Bank
Switzerland
$571K -$22.2K -459 -4%
Public Employees Retirement Association of Colorado
167
Public Employees Retirement Association of Colorado
Colorado
$561K – – –
DnB Asset Management
168
DnB Asset Management
Norway
$548K +$489K +10,122 New
ZIM
169
Zacks Investment Management
Illinois
$541K +$54.5K +1,128 +13%
RIA
170
Regal Investment Advisors
Michigan
$522K +$466K +9,635 New
MC
171
Maverick Capital
Texas
$490K +$438K +9,057 New
Wolverine Trading
172
Wolverine Trading
Illinois
$482K +$416K +8,602 New
E
173
Ergoteles
New York
$479K +$428K +8,842 New
PCM
174
Prelude Capital Management
New York
$469K +$1.26K +26 +0.3%
AP
175
AtonRa Partners
Switzerland
$463K -$45.8K -948 -10%
5 6
7
8 9

ITCI Hedge Fund Activity: Q1 2023 in Review

274 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q1 2023, worth a combined $4.55B — up 3.8% from $4.38B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of ITCI and 37 opened new positions — a net loss of 7 holders — while 86 trimmed existing stakes and 110 added.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $82.2M. The largest seller was Millennium Management, cutting an estimated $43.4M.

  • 274 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q1 2023, down from 283 in Q4 2022.
  • Funds reported $4.55B of Intra-Cellular Therapies Inc. stock for Q1 2023, up 3.8% quarter-over-quarter.
  • 37 funds opened new Intra-Cellular Therapies Inc. positions in Q1 2023 and 44 closed out, a net change of -7 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q1 2023 was Deep Track Capital, an estimated $82.2M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q1 2023 was Millennium Management, an estimated $43.4M sold.

Based on aggregated 13F filings for Q1 2023.